Full-Time

Senior Scientist

PhD, Immunology/T-Cell Biology

Confirmed live in the last 24 hours

Pfizer

Pfizer

10,001+ employees

Develops and manufactures vaccines and medicines

Biotechnology
Healthcare

Compensation Overview

$88.3k - $147.1kAnnually

+ Bonus

Senior

No H1B Sponsorship

La Jolla, San Diego, CA, USA + 1 more

More locations: United States

Work Location Assignment: On Premise; Relocation assistance may be available based on business needs and/or eligibility.

Category
Public Health
Biology Lab & Research
Biology & Biotech
Required Skills
Data Analysis
Requirements
  • PhD, in cancer biology, tumor immunology, immunology or a related field with 2+ years of relevant postdoctoral experience in an academic or pharmaceutical/biotech environment
  • A desire to continue in a laboratory-focused role and develop innovative methods to evaluate biological therapeutics for their impact on target biology and immune modulation
  • Expertise in tumor biology or immunology as evidenced by publication in peer-reviewed journals
  • Demonstrated proficiency in a wide range of immune assays and cellular techniques including mammalian cell culture, multicolor flow cytometry/FACS to immunophenotype murine and human cells from blood and tissues, and cytokine measurements from serum/plasma (MSD, Luminex, ELISA)
  • Strong knowledge of T cell biology with technical expertise in T cell-based functional assays (e.g. activation, differentiation, proliferation)
  • Strong ability to multi-task and work independently and efficiently in a fast-paced, highly collaborative in a diverse team environment with excellent communication skills and excellent leadership skills
  • Previous industry experience with target validation or evaluating drug combinations and a track record of success in immune-oncology drug discovery
  • Experience in writing technical study reports in support of regulatory filings
  • Prior experience in mentoring junior scientists
  • Extensive experience in cancer research, tumor microenvironment biology, immunology, or related fields, and a desire to continue in a laboratory-focused role
Responsibilities
  • Independently design, execute and analyze/interpret experiments to evaluate mechanism of action, elucidate mechanisms of resistance, and identify rational drug combinations that will advance preclinical and clinical stage IO programs
  • Participate at the project team level as a subject matter expert and effectively collaborate with other members of the Oncology Research Unit, including early research and discovery biology, computational biology, in vivo pharmacology, toxicology and drug pharmacokinetics teams
  • Proactively seek out novel methods in the literature and incorporate learnings to progress preclinical research and develop new experimental ways of testing hypotheses
  • Present research results and methodologies at routine meetings with immediate supervisor and/or project leader, project team meetings and other research forums
  • Forecast and plan resource requirements to meet the research goals as part of the project team
  • Record experimental protocols/results in detail and may write technical reports for regulatory filings
  • Supervise and mentor junior colleagues in experimental assay design, execution, and analysis
  • May occasionally engage and work with external collaborations and Contract Research Organizations (CROs)
  • Contribute to building a culture that embraces scientific excellence, urgency, partnerships with key stakeholders, continuous learning and improvement, increasing technical skill base and cancer biology expertise; take a proactive role in personal growth and scientific development

Pfizer is a biopharmaceutical company that focuses on creating and producing healthcare products, including medicines and vaccines. The company conducts extensive research and development to discover new treatments, which are then manufactured and sold to various clients such as governments, healthcare providers, and patients around the world. Pfizer's products include vaccines, oncology treatments, and other specialized medicines. A notable achievement is its partnership with BioNTech to develop a vaccine for COVID-19, which has played a significant role in addressing the pandemic. Pfizer aims to improve public health by ensuring access to vaccines, especially for underserved populations, and continues to grow its product offerings with new approvals and treatments.

Company Stage

IPO

Total Funding

$3.8B

Headquarters

New York City, New York

Founded

N/A

Simplify Jobs

Simplify's Take

What believers are saying

  • Pfizer's significant investments in companies like CellCentric and Caribou Biosciences indicate a strong focus on expanding its oncology and cell therapy capabilities.
  • The company's proactive approach in securing investments and partnerships positions it well for future growth and innovation in the biopharmaceutical sector.
  • Pfizer's involvement in funding rounds for promising biotech firms suggests potential for lucrative returns and strategic advancements in healthcare solutions.

What critics are saying

  • The slowdown in demand for COVID-19 vaccines could impact Pfizer's revenue and market perception.
  • Activist investor involvement, such as Starboard Value's $1 billion stake, may lead to pressure for strategic changes that could affect company stability.

What makes Pfizer unique

  • Pfizer's strategic partnerships and investments in innovative biotech companies like Promise Bio and Enara Bio highlight its commitment to cutting-edge research and development.
  • The company's collaboration with BioNTech for the COVID-19 vaccine showcases its ability to rapidly respond to global health crises, setting it apart from many competitors.
  • Pfizer's diverse portfolio, including oncology and specialized medicines, ensures a broad market reach beyond just vaccines.

Help us improve and share your feedback! Did you find this helpful?